Ellagic acid prevents α‐synuclein aggregation and protects sh‐sy5y cells from aggregated α‐synuclein‐induced toxicity via suppression of apoptosis and activation of autophagy

= Parkinson’s disease (PD) is a neurodegenerative disease characterized by the loss of do-pamine neurons and the deposition of misfolded proteins known as Lewy bodies (LBs), which con-tain α‐synuclein (α‐syn). The causes and molecular mechanisms of PD are not clearly understood to date. However, misfolded proteins, oxidative stress, and impaired autophagy are believed to play important roles in the pathogenesis of PD. Importantly, α‐syn is considered a key player in the development of PD. The present study aimed to assess the role of Ellagic acid (EA), a polyphenol found in many fruits, on α‐syn aggregation and toxicity. Using thioflavin and seeding polymeriza-tion assays, in addition to electron microscopy, we found that EA could dramatically reduce α‐syn aggregation. Moreover, EA significantly mitigated the aggregated α‐syn‐induced toxicity in SH‐ SY5Y cells and thus enhanced their viability. Mechanistically, these cytoprotective effects of EA are mediated by the suppression of apoptotic proteins BAX and p53 and a concomitant increase in the anti‐apoptotic protein, BCL‐2. Interestingly, EA was able to activate autophagy in SH‐SY5Y cells, as evidenced by normalized/enhanced expression of LC3‐II, p62, and pAKT. Together, our findings suggest that EA may attenuate α‐syn toxicity by preventing aggregation and improving viability by restoring autophagy and suppressing apoptosis.